Goetz C - Search Results

1

Disproportionality analysis of adverse neurological and psychiatric reactions with the ChAdOx1 (Oxford-AstraZeneca) and BNT162b2 (Pfizer-BioNTech) COVID-19 vaccines in the United Kingdom.

Otero-Losada M, Petrovsky N, Alami A, Crispo JA, Mattison D, Capani F, Goetz C, Krewski D, Perez-Lloret S. Otero-Losada M, et al. Among authors: goetz c. Expert Opin Drug Saf. 2023 Apr;22(4):343-349. doi: 10.1080/14740338.2022.2120607. Epub 2022 Sep 7. Expert Opin Drug Saf. 2023. PMID: 36043937

2

Rating Scales for Pain in Parkinson's Disease: Critique and Recommendations.

Perez-Lloret S, Ciampi de Andrade D, Lyons KE, Rodríguez-Blázquez C, Chaudhuri KR, Deuschl G, Cruccu G, Sampaio C, Goetz CG, Schrag A, Martinez-Martin P, Stebbins G; Members of the MDS Committee on Rating Scales Development. Perez-Lloret S, et al. Among authors: goetz cg. Mov Disord Clin Pract. 2016 Jun 24;3(6):527-537. doi: 10.1002/mdc3.12384. eCollection 2016 Nov-Dec. Mov Disord Clin Pract. 2016. PMID: 30363588 Free PMC article.

3

The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor symptoms of Parkinson's disease.

Seppi K, Weintraub D, Coelho M, Perez-Lloret S, Fox SH, Katzenschlager R, Hametner EM, Poewe W, Rascol O, Goetz CG, Sampaio C. Seppi K, et al. Among authors: goetz cg. Mov Disord. 2011 Oct;26 Suppl 3(0 3):S42-80. doi: 10.1002/mds.23884. Mov Disord. 2011. PMID: 22021174 Free PMC article. Review.

4

Short-term and practice effects of metronome pacing in Parkinson's disease patients with gait freezing while in the 'on' state: randomized single blind evaluation.

Cubo E, Leurgans S, Goetz CG. Cubo E, et al. Parkinsonism Relat Disord. 2004 Dec;10(8):507-10. doi: 10.1016/j.parkreldis.2004.05.001. Parkinsonism Relat Disord. 2004. PMID: 15542012 Clinical Trial.

5

Rating scale for psychogenic movement disorders: scale development and clinimetric testing.

Hinson VK, Cubo E, Comella CL, Goetz CG, Leurgans S. Hinson VK, et al. Mov Disord. 2005 Dec;20(12):1592-7. doi: 10.1002/mds.20650. Mov Disord. 2005. PMID: 16108025

6

The malignant course of "benign hallucinations" in Parkinson disease.

Goetz CG, Fan W, Leurgans S, Bernard B, Stebbins GT. Goetz CG, et al. Arch Neurol. 2006 May;63(5):713-6. doi: 10.1001/archneur.63.5.713. Arch Neurol. 2006. PMID: 16682540

7

Motor function in Parkinson's disease and supranuclear palsy: simultaneous factor analysis of a clinical scale in several populations.

Kroonenberg PM, Oort FJ, Stebbins GT, Leurgans SE, Cubo E, Goetz CG. Kroonenberg PM, et al. BMC Med Res Methodol. 2006 Jun 13;6:26. doi: 10.1186/1471-2288-6-26. BMC Med Res Methodol. 2006. PMID: 16772027 Free PMC article. Clinical Trial.

8

Neuropathic features in fragile X premutation carriers.

Berry-Kravis E, Goetz CG, Leehey MA, Hagerman RJ, Zhang L, Li L, Nguyen D, Hall DA, Tartaglia N, Cogswell J, Tassone F, Hagerman PJ. Berry-Kravis E, et al. Am J Med Genet A. 2007 Jan 1;143A(1):19-26. doi: 10.1002/ajmg.a.31559. Am J Med Genet A. 2007. PMID: 17152065

9

Comparison of tic characteristics between children and adults.

Cubo E, Chmura T, Goetz CG. Cubo E, et al. Mov Disord. 2008 Dec 15;23(16):2407-11. doi: 10.1002/mds.22117. Mov Disord. 2008. PMID: 18855922

10

The Unified Dyskinesia Rating Scale: presentation and clinimetric profile.

Goetz CG, Nutt JG, Stebbins GT. Goetz CG, et al. Mov Disord. 2008 Dec 15;23(16):2398-403. doi: 10.1002/mds.22341. Mov Disord. 2008. PMID: 19025759

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

865 results

Search Page